{{cart_num}}
My CartCAS：9003/11/6
Molecular Formula：No data available
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 9003/11/6 |
| Name | Poloxamer 407 |
| Molecular Formula | No data available |
| Solubility | Soluble in Water |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 618-355-0 |
| MDL | MFCD00082049 |
| Background | It is a non-ionic surfactant with special reverse thermal gelation, low irritation, good biocompatibility, and is an ideal drug controlled release material |
| Data Literature Source | [1]. Zhong CM，Li S，Wang XW，Chen D，Jiang ZL，Zhang C，He XJ，Huang C，Jiang YJ，Wu QC. MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation. Exp Cell Res. 2021 Jan 1;398(1):112402 |
| Unit | Bottle |
| Specification | 500mg 1g |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Tian W, et al. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1)1234-1240.
MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation
Click to check >>Author：Zhong CM;Li S;Wang XW;Chen D;Jiang ZL;Zhang C;He XJ;Huang C;Jiang YJ;Wu QC.
IF：3.7000
Publish_to：Exp Cell Res
PMID：33253710
Manual Download
